Condition
Non-Convulsive Status Epilepticus
Total Trials
5
Recruiting
1
Active
1
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 3 (2)
Trial Status
Completed4
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05263674Phase 3RecruitingPrimary
Fast Acute Sedation at Intensive Care vs. High-dose i.v. Anti-seizure Medication for Treatment of Non-convulsive Status Epilepticus (FAST-trial)
NCT05418634Completed
Point-of-care EEG in the Pediatric Emergency Department
NCT03138876Not ApplicableCompletedPrimary
EEG Cap for Identification of Non-Convulsive Status Epilepticus
NCT03534258CompletedPrimary
Does Use of Rapid Response EEG Impact Clinical Decision Making
NCT01586208Phase 3Completed
Refractory Status Epilepticus Treatment Study
Showing all 5 trials